Skip to main content
Tuesday, November 17, 2026Nov 17

About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds

FILE - A woman holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File)
FILE - A woman holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File)

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health condition tied to weight, but they are not broadly supportive of teens who have obesity using the medications, according to a new poll from The Associated Press-NORC Center for Public Affairs Research.

When it comes to ages 12 to 18 who are dealing with obesity, Americans are divided: About one-third say the use of weight-loss drugs in this context is a “very” or “somewhat” good thing, a similar share say it’s a bad thing and about 3 in 10 say it isn’t good or bad.

For adults, about half think it’s a good thing, and about 2 in 10 think it’s a bad thing.

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in popularity after the Food and Drug Administration approved them for weight loss in 2021. Now, they’re all over the place — celebrities, TV advertisements, social media, news media, your neighbor.

Doctors and researchers say the injectable drugs are a effective tools when it comes to treating obesity. The American Medical Association has urged health insurance companies to cover the drugs, and the American Academy of Pediatrics has said that doctors should consider giving the medications to kids 12 and older who are struggling with obesity.